Watch On-Demand
(originally recorded on March 25, 2010)
Manufacturers invest heavily into the development of products that deliver more effective treatment and many invest in the development and communication of a payer value proposition during the launch phase. Long-term growth requires consistent communication to address the payers’ need for value-based evidence as the brand matures.
We will deliver practical recommendations for how manufacturers can consistently develop and refine their product’s payer value proposition in order to maximize patient access while competitors launch, generic entrants threaten, new indications are approved, and policy/regulatory changes impact mature brands. Specifically, we will discuss:
Speakers:
Tom Mullin, MBA, Vice President of Business Development
Gene Reeder, RPh, PhD, Director of Payer Market Research
Learn more about upcoming opportunities to conduct market research sessions with our proprietary payer panel.